EUVIMEDEUVIMED entdecken
Crossref

26-A-18730-ACC OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION VERSUS CLASS III ANTIARRHYTHMICS AS FIRST-LINE THERAPY IN PATIENTS WITH SARCOIDOSIS AND VENTRICULAR TACHYCARDIA

Yong Hao Yeo, Tze Ern Ong, Aravinthan Vignarajah, Pattara Rattanawong, Christopher DeSimone, Hicham Z. El Masry, Justin Zon-Ern Lee, Dan Sorajja

JACC · 2026-04 · 87 (13) · A79-A80

DOI: 10.1016/j.jacc.2026.02.198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Yong Hao Yeo und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yeo, Y. H., Ong, T. E., Vignarajah, A., Rattanawong, P., DeSimone, C., Masry, H. Z. E., Lee, J. Z., & Sorajja, D. (2026). 26-A-18730-ACC OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION VERSUS CLASS III ANTIARRHYTHMICS AS FIRST-LINE THERAPY IN PATIENTS WITH SARCOIDOSIS AND VENTRICULAR TACHYCARDIA. JACC, 87(13), A79-A80. https://doi.org/10.1016/j.jacc.2026.02.198

Vancouver

Yeo YH, Ong TE, Vignarajah A, Rattanawong P, DeSimone C, Masry HZE, et al. 26-A-18730-ACC OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION VERSUS CLASS III ANTIARRHYTHMICS AS FIRST-LINE THERAPY IN PATIENTS WITH SARCOIDOSIS AND VENTRICULAR TACHYCARDIA. JACC. 2026;87(13):A79-A80. doi:10.1016/j.jacc.2026.02.198

BibTeX
@article{Yeo2026,
  author = {Yeo, Yong Hao and Ong, Tze Ern and Vignarajah, Aravinthan and Rattanawong, Pattara and DeSimone, Christopher and Masry, Hicham Z. El and Lee, Justin Zon-Ern and Sorajja, Dan},
  title = {26-A-18730-ACC OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION VERSUS CLASS III ANTIARRHYTHMICS AS FIRST-LINE THERAPY IN PATIENTS WITH SARCOIDOSIS AND VENTRICULAR TACHYCARDIA},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A79--A80},
  doi = {10.1016/j.jacc.2026.02.198}
}
Kostenlos starten →